Spring direct naar de hoofdnavigatie of de inhoud

Blijke Kroezen

Patent attorney

‘Innovation is the process of turning ideas into manufacturable and marketable form. (Watts Humprey)’
Blijke Kroezen

Blijke Kroezen

  • Life Sciences
  • Trainee Patent Attorney

Blijke Kroezen studied chemistry at the university of Groningen. For her Master’s research she worked on the development of novel medicines for malaria and tuberculosis. She was primarily responsible for the organic synthesis of the molecules, but was also involved in the design of the scaffolds using molecular modelling tools and the development of new in vitro assays to determine the affinity of the molecules.

Continue reading

She particularly enjoyed the multidisciplinary character of the research project and therefore decided in 2013 to pursue a PhD at the Faculty of Pharmaceutical Sciences at the University of Basel. During her PhD she started a new research project on the development of novel medicines for asthma. For four years, she specialized primarily in the design and synthesis of carbohydrates and carbohydrate-mimetics. In 2017, she obtained her PhD summa cum laude and in the same year she started as a trainee patent attorney at V.O.

Education

  • MSc in Chemistry, University of Groningen (2012)
  • PhD in Pharmaceutical Sciences, University of Basel (2017)

Publications

  • Masini, T., Pilger, J., Kroezen, B. S., Illarionov, B., Lottmann, P., Fischer, M., Griesinger C. and Hirsch, A. K. H., Chemical Science, 2014, 5, 3543-3551.
  • Masini, T., Kroezen, B.S., Hirsch, A.K.H., Drug Discovery Today, 2013, 18, 1256-1262.

Languages

  • Dutch
  • English
  • German

 

Also see these experts

Annemiek Tepper

Annemiek Tepper

  • European Patent Attorney
  • Dutch Patent Attorney
  • Senior Associate
Frits Michiels

Frits Michiels

  • European Patent Attorney
  • Dutch Patent Attorney
  • Senior Associate
More experts

News

The best-known medicine in the world: Aspirin

At the end of the 19th century, a young researcher from Bayer made one the most significant discoveries ever – the painkiller Aspirin. It was valuable for his employer, and also for his father who suffered from rheumatism. It led to a worldwide success!Continue reading

Potentially new opportunities for patents in the United States

In the USA, one of the requirements against which the conclusions of a patent application can be tested is whether it contains a matter that is eligible for patenting.Continue reading

New on Kluwer Patent Blog: Eli Lilly and Company vs. Fresenius Kabi Nederland B.V., Netherlands

By Bart van Wezenbeek. The scope of a patent is to be interpreted according to Art. 69 EPC and the Protocol. If the literal text is limiting, the question is how the skilled person would understand this limitation.Continue reading

Events

European Patent Seminar

Hotel Excelsior München, Schützenstraße, Munich, Germany

Know the latest ins-and-outs concerning examination, opposition and appeal proceedings before the EPO. Be updated on the unitary patent and the unified patent court. Continue reading

Improve your practical knowledge at the IP Academy – Basic

Winthontlaan 6, 3526 KV Utrecht, Utrecht, Netherlands

Follow the annual course on patents, trademarks and designs. For innovative entrepreneurs who wish to improve their intellectual property (IP) know-how, V.O. Patents & Trademarks organizes a basic course on IP on Thursday 26 September. Continue reading

IPBC Asia 2019

Palace Hotel Tokyo, 1 Chome-1-1 Marunouchi, Chiyoda City, Tokyo, Japan

Returning to Tokyo, IPBC Asia 2019 is set to be the largest yet – building on the phenomenal success of the event since its launch in 2013. IPBC Asia is focused on chief IP officers, heads of intellectual property or their equivalents at major corporates from across Asia-Pacific; and their counterparts at major multinationals Continue reading